Home › Funds › HighMark Wealth Management LLC › NPCE
HighMark Wealth Management LLC position in NPCE
NEUROPACE INC COM · Health Care
HighMark Wealth Management LLC reported holding 163,000 shares of NPCE (NEUROPACE INC COM) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.87% of its reported portfolio and ranking #20 among its reported holdings. HighMark Wealth Management LLC has disclosed NPCE holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How HighMark Wealth Management LLC's NPCE position evolved
HighMark Wealth Management LLC first disclosed a stake in NPCE in Q3 2024 at 3,000 shares (US$21K). The position peaked in Q2 2026 at 163,000 shares, worth US$2.6M. Across 8 filings, HighMark Wealth Management LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 163,000 shares valued at US$2.6M — an increase of 100,000 shares quarter over quarter.. Notable position changes include a 2000% increase in Q2 2025 (shares fell 7% over the following quarter), a 159% increase in Q2 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 3.00K | $20.91K | New |
| Q4 2024 | 3.00K | $33.57K | Hold |
| Q1 2025 | 3.00K | $36.87K | Hold |
| Q2 2025 | 63.00K | $701.82K | Add |
| Q3 2025 | 63.00K | $649.53K | Hold |
| Q4 2025 | 63.00K | $972.72K | Hold |
| Q1 2026 | 63.00K | $828.45K | Hold |
| Q2 2026 | 163.00K | $2.59M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NPCE and 13F data
NPCE (NEUROPACE INC COM) is a Health Care company. 47 other funds we track also report a position in NPCE — the largest reported positions include Soleus Capital Management, L.P. (US$46.3M), First Light Asset Management, LLC (US$45.5M), Palumbo Wealth Management LLC (US$3.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NPCE
- Soleus Capital Management, L.P. 2.91M sh · $46.26M · Q2 2026
- First Light Asset Management, LLC 2.86M sh · $45.46M · Q2 2026
- Palumbo Wealth Management LLC 209.20K sh · $3.32M · Q2 2026
More on HighMark Wealth Management LLC
FAQ
How long has HighMark Wealth Management LLC held NPCE?
HighMark Wealth Management LLC has disclosed NPCE holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is HighMark Wealth Management LLC's current position in NPCE?
As of Q2 2026, HighMark Wealth Management LLC holds 163.00K shares of NPCE (NEUROPACE INC COM), valued at $2.59M, representing 0.87% of its reported portfolio and ranking #20.
Has HighMark Wealth Management LLC been buying or selling NPCE?
In the latest 13F filing (Q2 2026), HighMark Wealth Management LLC increased its position in NPCE. The position peaked in Q2 2026 at 163.00K shares.
Which other funds hold NPCE?
Other major institutional holders of NPCE include Soleus Capital Management, L.P., First Light Asset Management, LLC, Palumbo Wealth Management LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.